Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 14.5B | 14.5B | 16.1B | 14.9B |
Cost of revenue | 4.3B | 4.4B | 5.1B | 4.4B |
Gross profit | 10.2B | 10.1B | 11.0B | 10.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.8B | 2.0B | 2.4B | 2.0B |
Other operating expenses | 2.5B | 2.6B | 2.5B | 2.4B |
Operating income | 4.6B | 4.1B | 4.6B | 4.7B |
Non operating interest income | ||||
Income | 38.8M | 0 | 564.6M | — |
Expense | 10.8M | 11.1M | 11.5M | 9.8M |
Other income expense | — | — | — | — |
Pretax income | 4.8B | 4.3B | 5.3B | 4.9B |
Tax provision | 1.2B | 1.1B | 1.4B | 1.3B |
Net income | 3.6B | 3.2B | 4.0B | 3.6B |
Basic EPS | — | 11.9 | 14.5 | 13.4 |
Diluted EPS | — | 11.9 | 14.5 | 13.4 |
Basic average shares | — | 271.9M | 272.1M | 272.0M |
Diluted average shares | — | 271.9M | 272.1M | 272.0M |
EBITDA | 5.2B | 4.7B | 5.7B | 5.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |